Maurice R. Ferré, M.D. is the founding President and Chief Executive Officer and current Chairman of the Board of Directors of MAKO Surgical Corp. In June 2007, he received the Ernst & Young Entrepreneur of the Year 2007 award for emerging companies in Florida. In 1993, Dr. Ferré founded Visualization Technology, Inc., a medical device company for image-guided surgery, where he served as Chief Executive Officer until April 2002 when Visualization Technology was acquired by GE Healthcare, the healthcare division of the General Electric Company.

Dr. Ferré served as Vice President of Strategic Development for GE Navigation, a Division of GE Healthcare from April 2002 until April 2004. In May 2004, Dr. Ferré became the Chief Executive Officer of Z-KAT, Inc., a surgical navigation device company, which eventually spun-off the orthopedic robotics segment that became the basis for the founding of MAKO Surgical. He holds an M.D. and a Master's degree in Public Health from Boston University.

S. Morry Blumenfeld, Ph.D. has served as one of our directors since July 2005. In 2003, Mr. Blumenfeld founded Meditech Advisors LLC and Meditech Advisors Management LLC, a general partner of Ziegler Meditech Equity Partners, LP, a private equity fund specializing in investments in healthcare and medical device companies. In April 2004, Mr. Blumenfeld retired as Managing Director of GE Medical Systems in Israel after 31 years with the company, where he initiated both GE's CT and MR business lines. Currently, he serves on the board of directors of a number of medical device and technology companies, including Oridion Systems Ltd. and several private companies. Mr. Blumenfeld holds a B.A.Sc in Engineering Physics and Ph.D. in Molecular Physics from the University of Toronto.

Gerald A. Brunk has served as one of our directors since October 2006. Mr. Brunk is a Managing Director at Lumira Capital Corp., a venture capital firm, which he joined in July 2002. From 2000 to 2002, Mr. Brunk was the Chief Operating Officer of ActiveCyte, Inc., a bioinformatics software company. During his career, Mr. Brunk has also served as a Manager in the healthcare practice of The Boston Consulting Group and as a member of the investment banking group at Credit Suisse First Boston. Currently, Mr. Brunk serves on the board of directors of ActivBiotics, Inc. and Cardiac Dimensions, Inc.. Mr. Brunk holds a B.A. from the University of Virginia and an M.B.A. from Stanford University Graduate School of Business.

Marcelo G. Chao has served as one of our directors since January 2007. He is a Managing Director at The Exxel Group, an affiliate of MK Investment Company, which he joined in March 2000. From 1995 to 2000, Mr. Chao was a Partner at Hermes Management Consulting. From 1992 to 1995, Mr. Chao was Vice-president of Citibank in Buenos Aires, Argentina, and from 1991 to 1992 he worked for McKinsey & Company. Currently, Mr. Chao serves on the board of directors of several portfolio companies. Between November 2002 and December 2006, Mr. Chao also served on the Latin American and Caribbean board of MasterCard International. Mr. Chao holds a B.S. in business administration from Universidad Católica Argentina and is a Certified Public Accountant.

Christopher C. Dewey has served as one of our directors since our inception in November 2004. Since January 2007, Mr. Dewey has served as Vice-Chairman of the board of directors of National Holdings Corporation, a financial services organization operating through its subsidiary, National Securities. Mr. Dewey also serves as acting Chief Executive Officer and director of Z-KAT, Inc. Mr. Dewey has over 25 years experience on Wall Street, most recently as Executive Vice President of Jefferies & Company, Inc. from 1994 to December 2006. Mr. Dewey co-founded several companies, including Robotic Ventures LLC, Bonds Direct Securities LLC and Cannon Group Inc., a motion picture company that went public in 1972. Mr. Dewey holds an MBA from The Wharton School of the University of Pennsylvania.

Charles W. Federico has served as one of our directors since June 2007. From 2001 to April 2006, Mr. Federico served as President and Chief Executive Officer of Orthofix International N.V. and; from 1996 to 2001, he served as President of Orthofix Inc. From 1985 to 1996, Mr. Federico was President of Smith & Nephew Endoscopy (formerly Dyonics, Inc.). From 1981 to 1985, Mr. Federico served as Vice President of Dyonics. Previously he held management and marketing positions with General Foods Corporation, Puritan Bennett Corporation and LSE Corporation. Mr. Federico is a Trustee of the Orthopaedic Research and Education Foundation and a director of Orthofix International N.V., SRI/Surgical Express, Inc., BioMimetic Therapeutics, Inc. and Alveolus, Inc. Mr. Federico holds a B.S. in marketing from Fordham University.

Frederic H. Moll, M.D. has served as one of our directors since August 2007. In September 2002, Mr. Moll co-founded Hansen Medical, Inc. and has served as its Chief Executive Officer and a director. In November 1995, Dr. Moll co-founded Intuitive Surgical Inc., a medical device company, and served as its first Chief Executive Officer and later, its Vice President and Medical Director until September 2003. In 1989, Dr. Moll co-founded Origin Medsystems, Inc., a medical device company, which later became an operating company within Guidant Corporation, a medical device company, following its acquisition by Eli Lilly in 1992. Dr. Moll served as Medical Director of Guidant's surgical device division until November 1995. Dr. Moll holds a B.A. from the University of California, Berkeley, an M.S. from Stanford University and an M.D. from the University of Washington School of Medicine.

William D. Pruitt has served as one of our directors since June 2008. Mr. Pruitt is the President of Pruitt Enterprises, LP. From 1980 to 1999, Mr. Pruitt was the Managing Partner for Arthur Andersen LLP's Florida, Caribbean and Venezuela operations. During his career, Mr. Pruitt has served on the board of directors as a Chairman of the audit committee for several companies. Mr. Pruitt has been a board member of The PBSJ Corporation since July 2005, and has been the Chairman of the company's audit committee since 2003. Mr. Pruitt served as Chairman of the audit committee of KOS Pharmaceuticals, Inc., a fully integrated specialty pharmaceutical company until its sale in 2006. He was also Chairman of the audit committee for Adjoined Consulting, Inc., a full-service management consulting firm, until it was merged into Kanbay International, a global consulting firm in February 2006. Mr. Pruitt has a Bachelor of Business Administration from the University of Miami and is a Certified Public Accountant (inactive).